Body mass index and breast cancer survival: a Mendelian randomization analysis
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Background: There is increasing evidence that elevated body mass index (BMI) is associated with reduced survival for women with breast cancer. However, the underlying reasons remain unclear. We conducted a Mendelian randomization analysis to investigate a possible causal role of BMI in survival from breast cancer. Methods: We used individual-level data from six large breast cancer case-cohorts including a total of 36 210 individuals (2475 events) of European ancestry. We created a BMI genetic risk score (GRS) based on genotypes at 94 known BMI-associated genetic variants. Association between the BMI genetic score and breast cancer survival was analysed by Cox regression for each study separately. Study-specific hazard ratios were pooled using fixed-effect meta-analysis. Results: BMI genetic score was found to be associated with reduced breast cancer-specific survival for estrogen receptor (ER)-positive cases [hazard ratio (HR) = 1.11, per one-unit increment of GRS, 95% confidence interval (CI) 1.01-1.22, P = 0.03). We observed no association for ER-negative cases (HR = 1.00, per one-unit increment of GRS, 95% CI 0.89-1.13, P = 0.95). Conclusions: Our findings suggest a causal effect of increased BMI on reduced breast cancer survival for ER-positive breast cancer. There is no evidence of a causal effect of higher BMI on survival for ER-negative breast cancer cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“MR analysis could avoid confounding factors and infer causality since the alleles of exposure genetic variants are randomly assigned [23].”
From Association between caffeine consumption and bone mineral density in children and adolescent: Observational and Mendelian randomization study (2023) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816 · cited 1×
“The role of directional pleiotropy was assessed using Egger regression on the summary statistics of association for each BMI-associated SNP with survival.(22) Egger regression is a modified form of standard inversevariance weighted meta-analysis.”
MethodSelf-citationMendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
Self-citationDavey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
Lawlor, D. A., Harbord, R. M., Sterne, J. A. C., Timpson, N., & Davey Smith, G. (2008) · Statistics in Medicine · doi:10.1002/sim.3034 · Cited by 4,618
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534 · cited 1×
“The Genetic Investigation of Anthropometric Traits (GIANT) consortium involving over 300 000 individuals of European descent has reported 97 common variants associated with BMI, of which three were only associated with BMI for men.(19) We used the genotype data described above to construct the BMI genetic risk score (…”
MethodChan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu042 · Cited by 1,165
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Protani, M., Coory, M., & Martin, J. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0990-0 · Cited by 962
Weight, Weight Gain, and Survival After Breast Cancer Diagnosis
Kroenke, C. H., Chen, W. Y., Rosner, B., & Holmes, M. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.079 · Cited by 670
Sample-Size Calculations for the Cox Proportional Hazards Regression Model with Nonbinary Covariates
Hsieh, F. Y., & Lavori, P. W. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00104-5 · Cited by 371
Obesity and Outcomes in Premenopausal and Postmenopausal Breast Cancer
Loi, S., Milne, R. L., Friedlander, M. L., McCredie, M. R. E., Giles, G. G., Hopper, J. L., & Phillips, K.-A. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0042 · Cited by 319
Self-citation
Cited by
Global patterns in excess body weight and the associated cancer burden
Sung, H., Siegel, R. L., Torre, L. A., Pearson‐Stuttard, J., Islami, F., Fedewa, S. A., Goding Sauer, A., Shuval, K., Gapstur, S. M., Jacobs, E. J., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21499 · Cited by 548
Self-citationStatistical methods for Mendelian randomization in genome-wide association studies: A review
Boehm, F. J., & Zhou, X. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.05.015 · Cited by 318
“Recently, multiple teams of investigators have analyzed time-to-event traits in MR studies [136-140].”
BackgroundCausal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization?
Yarmolinsky, J., Wade, K. H., Richmond, R. C., Langdon, R. J., Bull, C. J., Tilling, K. M., Relton, C. L., Lewis, S. J., Davey Smith, G., & Martin, R. M. (2018) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-1177 · Cited by 194
Contextualizing selection bias in Mendelian randomization: how bad is it likely to be?
Gkatzionis, A., & Burgess, S. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyy202 · Cited by 182
“dering a secondary disease outcome, such as disease progression. For example, a recent Mendelian randomization investigation considered the effect of body mass index (BMI) on breast cancer progression [16]. In order to be included in an analysis of disease progression, a participant must have had an initial disease eve…”
BackgroundSelf-citationBurgess, S., Mason, A. M., Grant, A. J., Slob, E. A. W., Gkatzionis, A., Zuber, V., Patel, A., Tian, H., Liu, C., Haynes, W. G., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.12.017 · Cited by 176
“144 Mendelian randomization analyses for disease progression are difficult to implement, as there is a natural selection event that may induce bias: disease progression can only be measured in individuals who have had an initial disease event.”
Self-citationLoos, R. J. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.02.009 · Cited by 129
Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
Escala-Garcia, M., Morra, A., Canisius, S., Chang-Claude, J. C., Kar, S., Zheng, W., Bojesen, S. E., Easton, D. F., Pharoah, P. D. P., & Schmidt, M. K. (2020) · BMC Medicine · doi:10.1186/s12916-020-01797-2 · Cited by 123
“The association of BMI with breast cancer-specific survival was previously evaluated in an earlier, smaller version of the BCAC dataset (n = 36,210) [41].”
BackgroundSelf-citationSystematic review of Mendelian randomization studies on risk of cancer
Markozannes, G., Kanellopoulou, A., Dimopoulou, O., Kosmidis, D., Zhang, X., Wang, L., Τheodoratou, E., Gill, D., Burgess, S., & Tsilidis, K. K. (2022) · BMC Medicine · doi:10.1186/s12916-022-02246-y · Cited by 107
Self-citationPang, Y., Wei, Y., & Kartsonaki, C. (2022) · Breast Cancer · doi:10.1007/s12282-022-01355-z · Cited by 87
“Moreover, a Mendelian randomization study showed that genetically predicted obesity is associated with all-cause mortality in ER+ BC patients and is not associated with allcause mortality in ER– BC patients [6].”
BackgroundMitchell, R. E., Hartley, A. E., Walker, V. M., Gkatzionis, A., Yarmolinsky, J. W., Bell, J. A., Chong, A., Paternoster, L., Tilling, K. M., & Smith, G. D. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010596 · Cited by 85
A framework for transcriptome-wide association studies in breast cancer in diverse study populations
Bhattacharya, A., García‐Closas, M., Olshan, A. F., Perou, C. M., Troester, M. A., & Love, M. I. (2020) · Genome biology · doi:10.1186/s13059-020-1942-6 · Cited by 81
Self-citationChan, D. S. M., Vieira, R. D. C. P. A., Abar, L., Aune, D., Balducci, K., Cariolou, M., Greenwood, D. C., Markozannes, G., Nanu, N., Becerra‐Tomás, N., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34322 · Cited by 78
“In addition, 119 publications were descriptively synthesized(139-257) and 156 publications were excluded.(258-413)”
BackgroundSex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study
Nounu, A., Kar, S., Relton, C. L., & Richmond, R. C. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01553-9 · Cited by 72
Modi, N. D., Tan, E., Rowland, A., Koczwara, B., Abuhelwa, A. Y., Kichenadasse, G., McKinnon, R. A., Wiese, M. D., Sorich, M. J., & Hopkins, A. M. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00241-9 · Cited by 57
Commentary: What can Mendelian randomization tell us about causes of cancer?
Mariosa, D., Carreras‐Torres, R., Martin, R. M., Johansson, M., & Brennan, P. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz151 · Cited by 46
“There are examples of MR studies investigating outcomes such as cancer mortality(30) or survival time.(31)”
BackgroundVincent, E. E., & Yaghootkar, H. (2020) · Diabetologia · doi:10.1007/s00125-020-05228-y · Cited by 45
“Several MR studies support a causal association between higher body fatness and risk of six obesity-related cancers [84], renal cell carcinoma [54], endometrial [85], ovarian [55, 86, 87], oesophageal [88], pancreatic [51, 89, 90] and colorectal cancer [87, 91] and reduced survival in oestrogen receptor-positive (ER+)…”
BackgroundApplying Mendelian randomization to appraise causality in relationships between nutrition and cancer
Wade, K. H., Yarmolinsky, J. W., Giovannucci, E. L., Lewis, S. J., Millwood, I. Y., Munafo, M. R., Meddens, S. F. W., Burrows, K., Bell, J. A., Davies, N. M., et al. (2022) · Cancer Causes & Control · doi:10.1007/s10552-022-01562-1 · Cited by 36
“As such, MR has been used to examine the causal roles of alcohol consumption on prostate cancer mortality in men with low-grade disease, coffee consumption on prostate cancer progression and BMI on breast cancer survival [44].”
Self-citationEarly breast cancer: why does obesity affect prognosis?
Heetun, A., Cutress, R., & Copson, E. (2018) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118000447 · Cited by 33
“and BCSS (HR 0·53) Guo et al.((110)) Mendelian randomisation analysis using”
Cheng, X., Shi, J., Zhang, D., Li, C., Xu, H., He, J., & Liang, W. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02502-8 · Cited by 32
“The second stage regression is substituted with either a Cox proportional hazard, or additive hazard regression, which required the outcome to make the Cox model valid [61].”
MethodCui, A., Xiao, P., Fan, Z., Lei, J., Han, S., Zhang, D.-L., Wei, X. C., Wang, P., & Zhuang, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1215790 · Cited by 28
“It could avoid confounding factors and infer causality since the alleles of exposure genetic variants are randomly assigned (19).”
BackgroundUpdate Breast Cancer 2018 (Part 2) – Advanced Breast Cancer, Quality of Life and Prevention
Schneeweiß, A., Lux, M. P., Janni, W., Hartkopf, A. D., Nabieva, N., Taran, F., Overkamp, F., Kolberg, H., Hadji, P., Tesch, H., et al. (2018) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0044-101614 · Cited by 25
Self-citationPu, B., Gu, P., Zheng, C., Ma, L., Zheng, X., & Zeng, Z. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.926190 · Cited by 25
Gagnon, É., & Arsenault, B. J. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117501 · Cited by 24
Koyratty, N., McCann, S. E., Millen, A. E., Nie, J., Trevisan, M., & Freudenheim, J. L. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1242 · Cited by 18
Coffee intake and risk of diabetic nephropathy: a Mendelian randomization study
Fang, J., Song, K., Zhang, D., Liang, Y., Zhao, H., Jin, J., & He, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1169933 · Cited by 18
Wade, K. H., Carslake, D., Tynelius, P., Smith, G. D., & Martin, R. M. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002868 · Cited by 17
Mendelian randomization analysis with survival outcomes
Cho, Y., Rau, A., Reiner, A. P., & Auer, P. L. (2020) · Genetic Epidemiology · doi:10.1002/gepi.22354 · Cited by 15
“We used the same 94 SNPs as in Guo et al. (2017) as instruments for BMI.”
BackgroundMethodInfluentialLi, L., Pope, C. N., Andridge, R., Bower, J. K., Hu, G., & Zhu, M. (2020) · Injury Epidemiology · doi:10.1186/s40621-020-00290-x · Cited by 16
Body mass index and type 2 diabetes and breast cancer survival: a Mendelian randomization study.
Liu, Y.-S., Wu, P., Chou, W., Vikram, R., Chen, W.-T., Yang, S.-L., Bolla, M. K., Wang, Q., Dennis, J., Chan, T. L., et al. (2021) · PubMed Central · doi:10.17863/cam.73616 · Cited by 15
Self-citationGuo, Z., Wang, J., Tian, X., Fang, Z., Gao, Y., Ping, Z., & Liu, L. (2022) · Public Health · doi:10.1016/j.puhe.2022.06.014 · Cited by 12
Díaz, B. C., Spínola-Maroño, H., Reynoso, N., González-Aguilar, A., & Mohar, A. (2019) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.12.018 · Cited by 12
Generalization vs. Specificity: In Which Cases Should a Clinic Train its Own Segmentation Models?
Schreier, J., Attanasi, F., & Laaksonen, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00675 · Cited by 12
Hua, X., Dai, J. Y., Lindström, S., Harrison, T. A., Lin, Y., Alberts, S. R., Alwers, E., Berndt, S. I., Brenner, H., Buchanan, D. D., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1848 · Cited by 10
Self-citationRate and pattern of road traffic accidents among older and younger drivers
Momtaz, Y. A., Kargar, R., Hosseiny, R., & Sahaf, R. (2018) · Healthy Aging Research · doi:10.12715/har.2018.7.8 · Cited by 10
Du, Y., Feng, R., Chang, E. T., Yin, L., Huang, T., Li, Y., Zhou, X., Huang, Y., Zhou, F., Su, C., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34524 · Cited by 9
Tianqi, Y., Zhou, Y., Wu, X., Fang, Z., & Liu, C. (2025) · Nature and Science of Sleep · doi:10.2147/nss.s524675 · Cited by 9
Yu, Y., Hou, L., Shi, X., Sun, X., Liu, X., Yu, Y., Yuan, Z., Li, H., & Xue, F. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010107 · Cited by 8
“…a case-control design [37]; A case-only study is used to explore the causal effect of BMI on breast cancer survival for ER-positive breast cancer [38]; Lp(a) was not associated with future cardiovascular mortality in the population of individuals who already established CHD [39]; Genetic…”
Li, H., Hou, L., Yu, Y., Sun, X., Liu, X., Yan, R., Yu, Y., Wu, S., Wu, Y., Wu, Y., et al. (2021) · Journal of Breast Cancer · doi:10.4048/jbc.2021.24.e53 · Cited by 8
“Consistent with our results, another MR study suggested that increased BMI could lower the breast cancer survival in ER-positive breast cancer patients [26].”
Ji, Z., Shen, Y., Chen, D., Liu, Z., Dai, J., Dai, B., & Deng, W. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1405161 · Cited by 7
A Bayesian approach for two‐stage multivariate Mendelian randomization with mixed outcomes
Deng, Y., Tu, D., O’Callaghan, C. J., Jonker, D. J., Karapetis, C. S., Shapiro, J. D., Liu, G., & Xu, W. (2023) · Statistics in Medicine · doi:10.1002/sim.9721 · Cited by 7
Cui, A., Xiao, P., He, J., Fan, Z., Xie, M., Chen, L., Zhuang, Y., & Wang, H. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287756 · Cited by 6
“MR analysis could avoid confounding factors and infer causality since the alleles of exposure genetic variants are randomly assigned [23].”
Yuan, Y., Tan, W., Huang, Y., Huang, H., Li, Y., Gou, Y., Zeng, S., & Hu, Z. (2023) · World Journal of Urology · doi:10.1007/s00345-023-04465-1 · Cited by 6
“Genetic variants are randomly assigned and fixed at conception to effectively reduce confounding bias and the possibility of reverse causality [13].”
BackgroundLink Between Obstructive Sleep Apnea and Kidney Stones: NHANES 2015–2018 and Mendelian Randomization
Liu, Y., Wang, L., Bao, E., Wang, J.-H., Yang, L., Wang, L., Xia, L., Wang, B., & Zhu, P.-Y. (2024) · Nature and Science of Sleep · doi:10.2147/nss.s483343 · Cited by 6
Zhang, W., Li, Z., Huang, Y., Zhao, J., Guo, S., Wang, Q., Guo, S., & Li, Q. (2025) · Cancer Medicine · doi:10.1002/cam4.70698 · Cited by 6
Self-citationChen, S.-B., Liu, D.-T., & Chen, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.769824 · Cited by 6
Dong, Y., Ding, W., Song, K., & Li, F. (2024) · American Journal of Rhinology and Allergy · doi:10.1177/19458924231225488 · Cited by 5
“23 In addition, all participants provided written informed consent prior to the study.”
BackgroundJohn, E. R., Crowther, M. J., Didelez, V., & Sheehan, N. A. (2024) · Statistical Methods in Medical Research · doi:10.1177/09622802241293765 · Cited by 4
“7 Both additive hazards and Cox IV methods have been applied to observational data, for example, Desai et al. 22 used an additive control function approach to assess the effect of osteoporosis medication use on subsequent fractures whereas Guo et al. 23 used a two-stage Cox IV model to consider the effect of body mass…”
Cui, A., Xiao, P., Wang, P., Wang, H., Cong, Y., Fan, Z., Wei, X., & Zhuang, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-60676-5 · Cited by 3
“It could avoid confounding factors and infer causality since the alleles of exposure genetic variants are randomly assigned 17 .”
Temporal dynamics of prognostic factors in breast cancer survival
Tvete, I. F., & Klemp, M. (2026) · PLoS ONE · doi:10.1371/journal.pone.0349115 · Cited by 1
“Overweight and obesity have been associated with poor prognosis and both overall and BC specific mortality, both for pre-and post-menopausal BC [10–12], partially mediated by tumor characteristics [13–14], although the literature is not unified [15].”
Zhang, L., Higgins, I. A., Dai, Q., Gkatzionis, A., Quistrebert, J., Bashir, N. Z., Dharmalingam, G., Bhatnagar, P., Gill, D., Liu, Y., et al. (2026) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2026.06.004 · Cited by 1
“68 There are several limitations to this investigation.”
Self-citationUpdate Mammakarzinom 2018 (Teil 2) – Fortgeschrittenes Mammakarzinom, Lebensqualität und Prävention
Schneeweiß, A., Lux, M. P., Janni, W., Hartkopf, A. D., Nabieva, N., Taran, F., Overkamp, F., Kolberg, H., Hadji, P., Tesch, H., et al. (2018) · Senologie - Zeitschrift für Mammadiagnostik und -therapie · doi:10.1055/s-0043-124850
“1093/ije/ dyx242 [80] Guo Q, Burgess S, Turman C et al.”
BackgroundSelf-citationFactors Affecting Nodal Status in Breast Cancer
Mira, M. A., Sarhan, A., Mohammed, S., & aboelata, D. (2020) · International Journal of Medical Arts · doi:10.21608/ijma.2020.24500.1105
Molina, A., & Elizabeth, C. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Afsa, R. A., Basal, A. A., Khadr, R., & Bahgat, Z. F. (2022) · Tanta Scientific Nursing Journal · doi:10.21608/tsnj.2022.255787
Tvete, I. F., & Klemp, M. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5051699
Fan, Z., Zhang, M., & Han, S. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.09.681515
“…BMI, a known risk factor for postmenopausal breast cancer, increases estrogen production by adipose tissue, promoting hormone receptor-positive cancers (Cheraghi, Zahra AND Poorolajal, Jalal AND Hashem, Tahereh AND Esmailnasab, Nader AND Doosti Irani,Amin 2012, 1–9; Guo et al. 2017, 1814–1822).”
Escala-Garcia, M., Morra, A., Canisius, S., Chang-Claude, J. C., Kar, S., Zheng, W., Bojesen, S. E., Easton, D. F., Pharoah, P. D. P., & Schmidt, M. K. (2020) · Figshare · doi:10.6084/m9.figshare.13245820
Self-citationLi, L., Pope, C. N., Andridge, R. R., Bower, J. K., Hu, G., & Zhu, M. (2020) · Figshare · doi:10.6084/m9.figshare.13324204
Cheng, X., Shi, J., Zhang, D., Li, C., Xu, H., He, J., & Liang, W. (2023) · Figshare · doi:10.6084/m9.figshare.23625375
Cheng, X., Shi, J., Zhang, D., Li, C., Xu, H., He, J., & Liang, W. (2023) · Figshare · doi:10.6084/m9.figshare.23625378
Escala-Garcia, M., Morra, A., Canisius, S., Chang-Claude, J. C., Kar, S., Zheng, W., Bojesen, S. E., Easton, D. F., Pharoah, P. D. P., & Schmidt, M. K. (2020) · Figshare · doi:10.6084/m9.figshare.13245823
Self-citationMbutiwi, F. I. N. (2023) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/1523
Germline copy number variation of cancer susceptibility 8 gene in breast cancer risk and prognosis
Kosunen, H. (2019) · UEF eRepo (University of Eastern Finland)
Saldaña, L. S., Lozada-Urbano, M. F., Sullcahuamán-Allende, Y., Cotrina, J. M., Velarde-Mendez, M., Chavez-Chocano, J., Rodríguez-Coyla, E., Zambrano-Jaimes, L., Mantilla, R., & Rosales‐Rimache, J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0341500
“Cellular iron is an essential nutrient; however, cancer cells exhibit dysregulated iron uptake, storage, and export, leading to increased oxidative stress and DNA damage [20,22,23].”
Precision nutrition in breast cancer: Towards patient- and tumour-informed dietary strategies
Crespo-Garcia, C., Taaffe, D. R., Peddle‐McIntyre, C. J., Jeffery, E., Campbell, J. P., Thomas, R., Galvao, D. A., & Newton, R. U. (2026) · Clinical Nutrition · doi:10.1016/j.clnu.2026.106670
Adiposity and risk of breast cancer in 280 000 Chinese women: a prospective cohort study
Kartsonaki, C., Wright, N., Millwood, I. Y., Pang, Y., Sun, D. J. Y., Pei, P., Schmidt, D., Stevens, R., Cao, Y., Du, H., et al. (2026) · International Journal of Epidemiology · doi:10.1093/ije/dyag155
“Adiposity is associated with poorer outcomes in breast cancer patients [41], which appears to be the case mainly for ER tumours [42], and a Mendelian randomization study has found it to be restricted to ER tumours [43].”
Pu, B., Gu, P., Zheng, C., Ma, L., Zheng, X., & Zeng, Z. (2022) · doi:10.3389/fnut.2022.926190.s001
Metadata
- Authors
- Guo, Q., Burgess, S., Turman, C., Bolla, M. K., Wang, Q., Lush, M., Abraham, J., Aittomäki, K., Andrulis, I. L., Apicella, C., Arndt, V., Barrdahl, M., Benitez, J., Berg, C. D., Blomqvist, C., Bojesen, S. E., Bonanni, B., Brand, J. S., Brenner, H., Broeks, A., Burwinkel, B., Caldas, C., Campa, D., Canzian, F., Chang-Claude, J., Chanock, S. J., Chin, S.-F., Couch, F. J., Cox, A., Cross, S. S., Cybulski, C., Czene, K., Darabi, H., Devilee, P., Diver, W. R., Dunning, A. M., Earl, H. M., Eccles, D. M., Ekici, A. B., Eriksson, M., Evans, D. G., Fasching, P. A., Figueroa, J., Flesch-Janys, D., Flyger, H., Gapstur, S. M., Gaudet, M. M., Giles, G. G., Glendon, G., Grip, M., Gronwald, J., Haeberle, L., Haiman, C. A., Hall, P., Hamann, U., Hankinson, S., Hartikainen, J. M., Hein, A., Hiller, L., Hogervorst, F. B., Holleczek, B., Hooning, M. J., Hoover, R. N., Humphreys, K., Hunter, D. J., Hüsing, A., Jakubowska, A., Jukkola-Vuorinen, A., Kaaks, R., Kabisch, M., Kataja, V., kConFab/AOCS Investigators, Knight, J. A., Koppert, L. B., Kosma, V.-M., Kristensen, V. N., Lambrechts, D., Le Marchand, L., Li, J., Lindblom, A., Lindström, S., Lissowska, J., Lubinski, J., Machiela, M. J., Mannermaa, A., Manoukian, S., Margolin, S., Marme, F., Martens, J. W., McLean, C., Menéndez, P., Milne, R. L., Marie Mulligan, A., Muranen, T. A., Nevanlinna, H., Neven, P., Nielsen, S. F., Nordestgaard, B. G., Olson, J. E., Perez, J. I., Peterlongo, P., Phillips, K.-A., Poole, C. J., Pylkäs, K., Radice, P., Rahman, N., Rüdiger, T., Rudolph, A., Sawyer, E. J., Schumacher, F., Seibold, P., Seynaeve, C., Shah, M., Smeets, A., Southey, M. C., Tollenaar, R. A. E. M., Tomlinson, I., Tsimiklis, H., Ulmer, H.-U., Vachon, C., van den Ouweland, A. M., Van’t Veer, L. J., Wildiers, H., Willett, W., Winqvist, R., Zamora, M. P., Chenevix-Trench, G., Dörk, T., Easton, D. F., García-Closas, M., Kraft, P., Hopper, J. L., Zheng, W., Schmidt, M. K., & Pharoah, P. D.
- Affiliations
- University of Cambridge (GB)
- Harvard University (US)
- University of Helsinki (FI)
- Mount Sinai Hospital (CA)
- The University of Melbourne (AU)
- German Cancer Research Center (DE)
- Spanish National Cancer Research Centre (ES)
- Division of Cancer Epidemiology and Genetics (US)
- University of Copenhagen (DK)
- European Institute of Oncology (IT)
- Karolinska Institutet (SE)
- The Netherlands Cancer Institute (NL)
- University of Pisa (IT)
- Mayo Clinic (US)
- University of Sheffield (GB)
- Pomeranian Medical University (PL)
- Leiden University Medical Center (NL)
- American Cancer Society (US)
- University of Southampton (GB)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Manchester Academic Health Science Centre (GB)
- University of California, Los Angeles (US)
- Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany,
- Herlev Hospital (DK)
- Oulu University Hospital (FI)
- University of Southern California (US)
- University of Massachusetts Amherst (US)
- University of Eastern Finland (FI)
- University of Warwick (GB)
- Krebsregister Saarland (DE)
- Erasmus MC Cancer Institute (NL)
- Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland,
- Oslo University Hospital (NO)
- VIB-KU Leuven Center for Cancer Biology (BE)
- University of Hawaii Cancer Center, Honolulu, HI, USA,
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
- Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland,
- Heidelberg University (DE)
- The Alfred Hospital (AU)
- University Health Network (CA)
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada,
- Universitair Ziekenhuis Leuven (BE)
- IFOM (IT)
- NordLab (FI)
- Institute of Cancer Research (GB)
- Guy's Hospital (GB)
- Centre for Human Genetics (GB)
- Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands,
- Division of Molecular Pathology, The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands,
- Hospital Universitario La Paz (ES)
- QIMR Berghofer Medical Research Institute (AU)
- Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia,
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA,
- Vanderbilt University (US)
- Corresponding author
- Guo, Qi
- ORCID
- Guo, Qi
- Burgess, Stephen
- Turman, Constance
- Bolla, Manjeet K
- Wang, Qin
- Lush, Michael
- Abraham, Jean
- Andrulis, Irene L
- Arndt, Volker
- Barrdahl, Myrto
- Benitez, Javier
- Berg, Christine D
- Blomqvist, Carl
- Bojesen, Stig E
- Bonanni, Bernardo
- Brand, Judith S
- Brenner, Hermann
- Broeks, Annegien
- Burwinkel, Barbara
- Caldas, Carlos
- Campa, Daniele
- Canzian, Federico
- Chang-Claude, Jenny
- Chanock, Stephen J
- Chin, Suet-Feung
- Couch, Fergus J
- Cox, Angela
- Cross, Simon S
- Cybulski, Cezary
- Czene, Kamila
- Devilee, Peter
- Diver, W Ryan
- Dunning, Alison M
- Earl, Helena M
- Eccles, Diana M
- Ekici, Arif B
- Eriksson, Mikael
- Evans, D Gareth
- Fasching, Peter A
- Figueroa, Jonine
- Gapstur, Susan M
- Gaudet, Mia M
- Giles, Graham G
- Gronwald, Jacek
- Hall, Per
- Hamann, Ute
- Hankinson, Susan
- Hartikainen, Jaana M
- Hein, Alexander
- Hiller, Louise
- Holleczek, Bernd
- Hooning, Maartje J
- Hoover, Robert N
- Humphreys, Keith
- Hüsing, Anika
- Jakubowska, Anna
- Kaaks, Rudolf
- Kataja, Vesa
- Knight, Julia A
- Koppert, Linetta B
- Kosma, Veli-Matti
- Kristensen, Vessela N
- Lambrechts, Diether
- Li, Jingmei
- Lindblom, Annika
- Lindström, Sara
- Lissowska, Jolanta
- Machiela, Mitchell J
- Manoukian, Siranoush
- Margolin, Sara
- Martens, John WM
- McLean, Catriona
- Milne, Roger L
- Muranen, Taru A
- Nevanlinna, Heli
- Neven, Patrick
- Nielsen, Sune F
- Nordestgaard, Børge G
- Olson, Janet E
- Peterlongo, Paolo
- Phillips, Kelly-Anne
- Pylkäs, Katri
- Radice, Paolo
- Rahman, Nazneen
- Rüdiger, Thomas
- Rudolph, Anja
- Sawyer, Elinor J
- Schumacher, Fredrick
- Seibold, Petra
- Shah, Mitul
- Smeets, Ann
- Southey, Melissa C
- Tollenaar, Rob A E M
- Tomlinson, Ian
- Tsimiklis, Helen
- Vachon, Celine
- Wildiers, Hans
- Willett, Walter
- Winqvist, Robert
- Zamora, M Pilar
- Dörk, Thilo
- Easton, Douglas F
- Kraft, Peter
- Hopper, John L
- Zheng, Wei
- Schmidt, Marjanka K
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-10-09
- Volume
- 46
- Issue
- 6
- Pages
- 1814-1822
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- PMC
- PMC5837506
- OpenAlex
- W2613921192
- Cited by
- 64
- References
- 24
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 7 · 2023: 11 · 2022: 11 · 2021: 5 · 2020: 10 · 2019: 3 · 2018: 9
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- International Journal of Epidemiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (publishedVersion, cc-by)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- UEF eRepo (University of Eastern Finland) (acceptedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- Explore Bristol Research (submittedVersion, cc-by)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Työväentutkimus Vuosikirja (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion, cc-by)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- Funders
- Wellcome Trust (204623/Z/16/Z, 100114)
- Francis Crick Institute (10124)
- Cancer Research UK (A7572, 19187, C1287‐A10118, 16561, 15106, C1287/ A12014, A11699, A16561, 10124, 16942)
- National Institute for Health and Care Research (NF-SI-0512-10165, NF-SI-0515-10090, NF-SI-0611-10154)
- British Heart Foundation (RG/08/014/24067)
- Medical Research Council (MR/L003120/1)
- National Cancer Institute (P50CA116201)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- body mass index, breast cancer survival, estrogen receptor-positive breast cancer, estrogen receptor-negative breast cancer, obesity, breast cancer-specific survival
- MeSH terms
- Breast Neoplasms, Europe, Female, Humans, Receptors, Estrogen, Risk Factors, Genetic Variation, Meta-Analysis as Topic, Causality, Body Mass Index, Survival Analysis, Risk Assessment, Polymorphism, Single Nucleotide, White People, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.